SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 226 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $390 | -36.1% | 12,974 | -22.9% | 0.05% | -12.5% |
| Q1 2023 | $610 | -8.5% | 16,830 | -10.1% | 0.06% | -16.4% |
| Q4 2022 | $667 | -99.9% | 18,711 | -26.3% | 0.07% | -18.3% |
| Q4 2021 | $740,000 | +239.4% | 25,382 | +205.5% | 0.08% | +228.0% |
| Q1 2021 | $218,000 | -14.2% | 8,309 | +9.0% | 0.02% | -43.2% |
| Q4 2018 | $254,000 | -66.0% | 7,626 | -59.2% | 0.04% | -66.7% |
| Q4 2017 | $746,000 | – | 18,704 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |